Key result
Synthetic atrial natriuretic factor infusion decreased pulmonary capillary wedge pressure by >50% (from 16 to 7 mmHg, p<0.01) without reflex tachycardia or volume depletion in acute MI patients.
Why the study?
Does 24-hour intravenous infusion of synthetic atrial natriuretic factor improve hemodynamic parameters in patients with acute myocardial infarction?
Population
8 patients with acute myocardial infarction. Excluded: cardiogenic shock, life-threatening arrhythmias, and…
Design
Case_series
Follow-up
24 hours
Authors
Loading...
ANF infusion appears feasible in AMI; leaves open clinical utility pending controlled trials.
Does 24-hour intravenous infusion of synthetic atrial natriuretic factor improve hemodynamic parameters in patients with acute myocardial infarction?
Absolute Event Rate: 7% vs 16%
p-value: p=<0.01
Prolonged 24-hour infusion of synthetic ANF in patients with acute myocardial infarction safely produces potent and sustained left ventricular unloading without reflex tachycardia or volume depletion.
Nakamura et al. (1993) studied Acute myocardial infarction (n=8). Synthetic Atrial Natriuretic Factor vs. Baseline was evaluated on Pulmonary capillary wedge pressure at 4 hours (p=<0.01). Synthetic atrial natriuretic factor infusion decreased pulmonary capillary wedge pressure by >50% (from 16 to 7 mmHg, p<0.01) without reflex tachycardia or volume depletion in acute MI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: